Summary
Songjun Xu is an Associate Director and computational biologist with nine years of experience translating genomics, proteomics, and single-cell data into actionable insights for drug discovery and clinical strategy. He has led oncology-focused data science programs that proposed novel drug candidates, improved predictive accuracy using transformer-based deep learning, and optimized trial designs across multiple solid tumor studies. His work spans target discovery, safety risk modeling, and biomarker identification, informed by a strong academic track record including a Penn postdoc and a PhD in Human Genetics. Comfortable operating in matrixed pharmaceutical environments, he combines hands-on pipeline development and algorithm design with stakeholder-facing communication to drive milestone decisions. A practical innovator, he pairs wet-lab understanding (CRISPR and epigenetics) with scalable computational frameworks to shorten translational timelines.
8 years of coding experience
7 years of employment as a software developer
Doctor of Philosophy - PhD Human Genetics and Genomics, Doctor of Philosophy - PhD Human Genetics and Genomics at Drexel University
Bachelor of Science - BS Bioinformatics, Bachelor of Science - BS Bioinformatics at Huazhong University of Science and Technology
postdoc Department of Systems Pharmacology and Translational Therapeutics, postdoc Department of Systems Pharmacology and Translational Therapeutics at University of Pennsylvania
English, Chinese